-+ 0.00%
-+ 0.00%
-+ 0.00%

ROCHE RECEIVES FDA DE NOVO AUTHORIZATION FOR COBAS® PRO I 601 PLATFORM WITH IONIFY® GABAPENTIN ASSAY, ADVANCING AUTOMATED MASS SPECTROMETRY FOR ROUTINE CLINICAL LABORATORIES

Reuters·11/16/2026 14:02:31